Trial Profile
Efficacy and safety of Factor-VIII/von Willebrand factor in patients with Von Willebrand's disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jun 2014
Price :
$35
*
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Therapeutic Use
- 26 Jun 2014 New trial record